Fundraising Fox

Fina Biosolutions

Rockville, US · Maryland LLC

Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.

Founders & leadership

AL
Andrew LeesCEO and Chief Scientific Officer

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2024

$3MraisedNov 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew LeesExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
First sale
Nov 2024
Incorporated
Limited Liability Company, Maryland
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Fina Biosolutions for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Fina Biosolutions do?
Fina BioSolutions produces CRM197 carrier proteins used in vaccine development and research, offering both research-grade and cGMP-certified versions through an efficient E. coli expression system.
How much funding has Fina Biosolutions raised?
Fina Biosolutions has disclosed $3M raised across 1 round.
Where is Fina Biosolutions headquartered?
Fina Biosolutions is headquartered in Rockville, US.